Posted in | News | Graphene

Graphene Engineering & Innovation Centre Advisory Panel Visits Thomas Swan’s Facilities

In early January senior members from The University of Manchester’s GEIC advisory panel visited Thomas Swan in Consett, County Durham, to gain a better understanding of the process engineering, utilities, logistics, technology and safety requirements for a modern materials manufacturing facility.

The team from the University of Manchester, GEIC Industry Advisory panel views part of the carbon nanomaterials manufacturing plant at Thomas Swan, Consett.

Thomas Swan is well established as a reliable manufacturer of quality carbon nanomaterials – initially as a supplier of carbon nanotubes and now as a leading supplier of high quality graphene.

As a member of the GEIC Industry Advisory Panel, Thomas Swan invited the team to visit the Consett site for improved insight into modern chemical processing to assist in the concept and design of the new £60M graphene research centre.

“We are pleased to support the GEIC team in developing the strategy and plans for the new facility in Manchester. We hope that by collaborating at this early stage we can help guide the development of the new facility which will support UK manufacturing companies and in particular the needs of SME’s such as Thomas Swan” said Andy Goodwin, Commercial Director – Advanced Materials Division.

“We view partnership with academic centres and government supported facilities as essential to de-risk investment in materials innovation. We are excited by and look forward to collaborating with the world class expertise which is being developed and strengthened at The University of Manchester” added Goodwin.

James Baker, Business Director for the National Graphene Institute (NGI) said: “Visiting the fantastic facilities at Thomas Swan has been thoroughly informative. The NGI and the forthcoming GEIC facilities will make sure research at the University goes hand-in-hand with collaboration with industry and SMEs in particular. The infrastructure we are putting in place in Manchester will lead to a critical mass of world-leading graphene focused academics and industry working alongside one another."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas Swan & Co Ltd. (2019, February 11). Graphene Engineering & Innovation Centre Advisory Panel Visits Thomas Swan’s Facilities. AZoNano. Retrieved on October 10, 2024 from https://www.azonano.com/news.aspx?newsID=31901.

  • MLA

    Thomas Swan & Co Ltd. "Graphene Engineering & Innovation Centre Advisory Panel Visits Thomas Swan’s Facilities". AZoNano. 10 October 2024. <https://www.azonano.com/news.aspx?newsID=31901>.

  • Chicago

    Thomas Swan & Co Ltd. "Graphene Engineering & Innovation Centre Advisory Panel Visits Thomas Swan’s Facilities". AZoNano. https://www.azonano.com/news.aspx?newsID=31901. (accessed October 10, 2024).

  • Harvard

    Thomas Swan & Co Ltd. 2019. Graphene Engineering & Innovation Centre Advisory Panel Visits Thomas Swan’s Facilities. AZoNano, viewed 10 October 2024, https://www.azonano.com/news.aspx?newsID=31901.

Comments

  1. Rob Munro | Innovate for Growth Rob Munro | Innovate for Growth United Kingdom says:

    Exciting news!  The key to process development and scale up of advanced functional materials (like Graphene and catalysts) is to develop excellent process understanding. This is done by building the right pilot plant and subsequent demonstration but also using a framework of thinking about what chemistry and physics is going on a different scales. Good luck, GEIC @NGI.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoNano.com.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.